$ALXN Headlines Bed Bath, Starz gain; Citizens
Post# of 145202
Posted On: 09/25/2014 10:32:22 AM
$ALXN Headlines
Bed Bath, Starz gain; Citizens Financial debuts 3:52 p.m. Sept. 24, 2014 - Sue Chang
S&P 500 ekes out another record close: stock market live blog recap 4:03 p.m. July 24, 2014 - blogs.marketwatch.com
Biotechs beat estimates, but the Street wants more 11:44 a.m. July 24, 2014 - Russ Britt
22 stocks that may be the gems of earnings season 3:12 a.m. July 10, 2014 - blogs.marketwatch.com
Oracle slides on disappointing results; CarMax soars 4:17 p.m. June 20, 2014 - Sue Chang
Alexion rises 1.4%, among biggest S&P 500 gainers 9:32 a.m. June 6, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Corner drug store may move overseas to save on taxes 6:31 a.m. April 16, 2014 - Al Lewis
Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 4:53 p.m. April 10, 2014 - blogs.marketwatch.com
TripAdvisor, Tesla sink as momentum plays lose favor 4:36 p.m. April 10, 2014 - Sue Chang
Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - Russ Britt
Tesla, Facebook, Netflix are Monday’s stocks to watch 5:35 a.m. April 7, 2014 - Sue Chang
Facebook, Tesla slide into bear market territory 4:52 p.m. April 4, 2014 - Sue Chang
Investors continue to pour out of biotech holdings 2:43 p.m. April 4, 2014 - Russ Britt
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 4:41 p.m. March 24, 2014 - Anora Mahmudova
Apple gains on Comcast talk, new iPhone buzz 4:24 p.m. March 24, 2014 - Sue Chang
First Solar, H-P, Symantec are stocks to watch 4:16 p.m. March 21, 2014 - Sue Chang
First Solar extends winning streak; Symantec plunges 3:07 p.m. March 21, 2014 - Sue Chang
From every angle, technicals point to richer stocks 2:26 p.m. March 11, 2014 - The Trading Deck
5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential 7:41 a.m. Today - 247WallSt.com
Biotech Stock Roundup: Auxilium an Acquisition Target, Amgen Submits another BLA - Analyst Blog 11:05 a.m. Sept. 24, 2014 - Zacks.com
Alexion Pharmaceuticals, Inc. (ALXN): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Sept. 23, 2014 - Zacks.com
Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst Blog 3:20 p.m. Sept. 22, 2014 - Zacks.com
IBD 50 Stocks Setting Up, Including These 5 Medicals 5:35 p.m. Sept. 19, 2014 - Investors Business Daily
Encouraging Phase 2 results for Alexion's asfotase alfa 7:42 a.m. Sept. 19, 2014 - Seeking Alpha
SNN, ALXN And ACT, 3 Health Care Stocks Pushing The Sector Lower 1:04 p.m. Sept. 17, 2014 - TheStreet.com
Stock Market News for September 17, 2014 - Market News 10:10 a.m. Sept. 17, 2014 - Zacks.com
If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits 8:00 a.m. Sept. 16, 2014 - Seeking Alpha
3 Hot Ways to Play the Biotechnology Bonanza 6:36 a.m. Sept. 16, 2014 - InvestorPlace.com
Biotech Stocks With Upside Target Ebola, Liver Disease 6:30 a.m. Sept. 16, 2014 - InvestorPlace.com
Is Intercept Pharmaceuticals Building The Next Great Specialty Franchise? 2:30 p.m. Sept. 15, 2014 - Seeking Alpha
Stock Market News for September 11, 2014 - Market News 10:10 a.m. Sept. 11, 2014 - Zacks.com
Trading Guidelines for Amgen, Biogen Idec, Gilead, 3 Other Biotechs 10:02 a.m. Sept. 11, 2014 - TheStreet.com
Short Sellers Remain Vigilant Against Biotechs 9:45 a.m. Sept. 11, 2014 - 247WallSt.com
Alexion's Asfotase Alfa Gets Japanese Orphan Drug Status - Analyst Blog 5:30 p.m. Sept. 9, 2014 - Zacks.com
SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks 8:58 a.m. Sept. 8, 2014 - 247WallSt.com
Japanese regulators tag asfotase alfa an orphan drug for rare bone disorder 7:06 a.m. Sept. 8, 2014 - Seeking Alpha
Alexion Pharmaceuticals: FDA Findings An Easy Fix 5:45 p.m. Sept. 5, 2014 - Investors Business Daily
Insider Trading Alert - BRCM, ALXN And JLL Traded By Insiders 12:03 p.m. Sept. 5, 2014 - TheStreet.com
Paediatric Patients with Hypophosphatasia Receiving Investigational Asfotase Alfa Had Sustained Improvements in Growth and Physical Function 4:49 a.m. Sept. 19, 2014 - BusinessWire - BZX
Alexion Strengthens and Broadens Its Executive Leadership Team 7:30 a.m. Sept. 17, 2014 - BusinessWire - BZX
Improved Survival Observed in Pediatric Patients with Severe Hypophosphatasia (HPP) Who Were Treated with Investigational Asfotase Alfa for Up to Five Years 5:30 p.m. Sept. 14, 2014 - BusinessWire - BZX
NICE Recommends Commissioning of Eculizumab (Soliris®) for All Patients with aHUS in England 7:01 p.m. Sept. 3, 2014 - BusinessWire - BZX
Technical Updates, Upcoming Conferences, Drug Trials, and Acquisition Updates - Research Reports on SL Green, Allstate, HCA Holdings, Alexion and Salix 9:15 a.m. Sept. 3, 2014 - PR Newswire - PRF
Alexion to Present at Investor Conferences 10:00 a.m. Aug. 28, 2014 - BusinessWire - BZX
Collaborations, Upcoming Seminar, Clinical Trial Results, Data Presentation Schedule - Research Reports on AstraZeneca, Illumina, Novartis, Lilly and Alexion 8:30 a.m. Aug. 26, 2014 - PR Newswire - PRF
Alexion Initiates Multinational Registration Trial of Eculizumab for the Prevention of Delayed Graft Function (DGF) after Kidney Transplantation 6:30 a.m. Aug. 25, 2014 - BusinessWire - BZX
Technical Updates, Study Outcomes, Project Approvals, and Quarterly Performance Reviews - Research Reports on Alexion, Novartis, CB&I, L-3 and Emerson 8:40 a.m. Aug. 15, 2014 - PR Newswire - PRF
Researchers to Present New Data on Asfotase Alfa in Pediatric Patients with Hypophosphatasia at the American Society for Bone and Mineral Research 2014 Annual Meeting 4:57 p.m. Aug. 13, 2014 - BusinessWire - BZX
Cannabis Should Be Treated as an Agricultural Commodity, Not a Biotech Investment 2:44 p.m. Aug. 11, 2014 - ACCESSWIRE
Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma 8:40 a.m. Aug. 11, 2014 - PR Newswire - PRF
Financial Results, FDA Approvals, Orphan Drug Designations, and Certificates - Research Reports on Idenix, Baxter, Alexion, Alere and Zoetis 9:10 a.m. Aug. 7, 2014 - PR Newswire - PRF
European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG) 6:30 a.m. Aug. 1, 2014 - BusinessWire - BZX
Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis 8:40 a.m. July 29, 2014 - PR Newswire - PRF
European Medicines Agency Accepts Marketing Authorization Application for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia 6:15 a.m. July 24, 2014 - BusinessWire - BZX
Leadership Appointments, Earnings Conference Calls, Milestone Payments, and Technical Updates - Analyst Notes on Illumina, Alexion, Incyte, Clovis and Keryx 8:10 a.m. July 17, 2014 - PR Newswire - PRF
Alexion Announces the Appointments of David R. Brennan, M. Michele Burns and Christopher J. Coughlin to Its Board of Directors 8:02 a.m. July 16, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals to Report Second Quarter 2014 Results on Thursday, July 24, 2014 10:00 a.m. July 10, 2014 - BusinessWire - BZX
Market Activity and Upcoming Quarterly Results - Analyst Notes on Bristol-Myers Squibb, Abbott, Alexion, Mallinckrodt and Baxter 6:10 a.m. July 8, 2014 - PR Newswire - PRF
Bed Bath, Starz gain; Citizens Financial debuts 3:52 p.m. Sept. 24, 2014 - Sue Chang
S&P 500 ekes out another record close: stock market live blog recap 4:03 p.m. July 24, 2014 - blogs.marketwatch.com
Biotechs beat estimates, but the Street wants more 11:44 a.m. July 24, 2014 - Russ Britt
22 stocks that may be the gems of earnings season 3:12 a.m. July 10, 2014 - blogs.marketwatch.com
Oracle slides on disappointing results; CarMax soars 4:17 p.m. June 20, 2014 - Sue Chang
Alexion rises 1.4%, among biggest S&P 500 gainers 9:32 a.m. June 6, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Corner drug store may move overseas to save on taxes 6:31 a.m. April 16, 2014 - Al Lewis
Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 4:53 p.m. April 10, 2014 - blogs.marketwatch.com
TripAdvisor, Tesla sink as momentum plays lose favor 4:36 p.m. April 10, 2014 - Sue Chang
Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - Russ Britt
Tesla, Facebook, Netflix are Monday’s stocks to watch 5:35 a.m. April 7, 2014 - Sue Chang
Facebook, Tesla slide into bear market territory 4:52 p.m. April 4, 2014 - Sue Chang
Investors continue to pour out of biotech holdings 2:43 p.m. April 4, 2014 - Russ Britt
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 4:41 p.m. March 24, 2014 - Anora Mahmudova
Apple gains on Comcast talk, new iPhone buzz 4:24 p.m. March 24, 2014 - Sue Chang
First Solar, H-P, Symantec are stocks to watch 4:16 p.m. March 21, 2014 - Sue Chang
First Solar extends winning streak; Symantec plunges 3:07 p.m. March 21, 2014 - Sue Chang
From every angle, technicals point to richer stocks 2:26 p.m. March 11, 2014 - The Trading Deck
5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential 7:41 a.m. Today - 247WallSt.com
Biotech Stock Roundup: Auxilium an Acquisition Target, Amgen Submits another BLA - Analyst Blog 11:05 a.m. Sept. 24, 2014 - Zacks.com
Alexion Pharmaceuticals, Inc. (ALXN): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Sept. 23, 2014 - Zacks.com
Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst Blog 3:20 p.m. Sept. 22, 2014 - Zacks.com
IBD 50 Stocks Setting Up, Including These 5 Medicals 5:35 p.m. Sept. 19, 2014 - Investors Business Daily
Encouraging Phase 2 results for Alexion's asfotase alfa 7:42 a.m. Sept. 19, 2014 - Seeking Alpha
SNN, ALXN And ACT, 3 Health Care Stocks Pushing The Sector Lower 1:04 p.m. Sept. 17, 2014 - TheStreet.com
Stock Market News for September 17, 2014 - Market News 10:10 a.m. Sept. 17, 2014 - Zacks.com
If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits 8:00 a.m. Sept. 16, 2014 - Seeking Alpha
3 Hot Ways to Play the Biotechnology Bonanza 6:36 a.m. Sept. 16, 2014 - InvestorPlace.com
Biotech Stocks With Upside Target Ebola, Liver Disease 6:30 a.m. Sept. 16, 2014 - InvestorPlace.com
Is Intercept Pharmaceuticals Building The Next Great Specialty Franchise? 2:30 p.m. Sept. 15, 2014 - Seeking Alpha
Stock Market News for September 11, 2014 - Market News 10:10 a.m. Sept. 11, 2014 - Zacks.com
Trading Guidelines for Amgen, Biogen Idec, Gilead, 3 Other Biotechs 10:02 a.m. Sept. 11, 2014 - TheStreet.com
Short Sellers Remain Vigilant Against Biotechs 9:45 a.m. Sept. 11, 2014 - 247WallSt.com
Alexion's Asfotase Alfa Gets Japanese Orphan Drug Status - Analyst Blog 5:30 p.m. Sept. 9, 2014 - Zacks.com
SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks 8:58 a.m. Sept. 8, 2014 - 247WallSt.com
Japanese regulators tag asfotase alfa an orphan drug for rare bone disorder 7:06 a.m. Sept. 8, 2014 - Seeking Alpha
Alexion Pharmaceuticals: FDA Findings An Easy Fix 5:45 p.m. Sept. 5, 2014 - Investors Business Daily
Insider Trading Alert - BRCM, ALXN And JLL Traded By Insiders 12:03 p.m. Sept. 5, 2014 - TheStreet.com
Paediatric Patients with Hypophosphatasia Receiving Investigational Asfotase Alfa Had Sustained Improvements in Growth and Physical Function 4:49 a.m. Sept. 19, 2014 - BusinessWire - BZX
Alexion Strengthens and Broadens Its Executive Leadership Team 7:30 a.m. Sept. 17, 2014 - BusinessWire - BZX
Improved Survival Observed in Pediatric Patients with Severe Hypophosphatasia (HPP) Who Were Treated with Investigational Asfotase Alfa for Up to Five Years 5:30 p.m. Sept. 14, 2014 - BusinessWire - BZX
NICE Recommends Commissioning of Eculizumab (Soliris®) for All Patients with aHUS in England 7:01 p.m. Sept. 3, 2014 - BusinessWire - BZX
Technical Updates, Upcoming Conferences, Drug Trials, and Acquisition Updates - Research Reports on SL Green, Allstate, HCA Holdings, Alexion and Salix 9:15 a.m. Sept. 3, 2014 - PR Newswire - PRF
Alexion to Present at Investor Conferences 10:00 a.m. Aug. 28, 2014 - BusinessWire - BZX
Collaborations, Upcoming Seminar, Clinical Trial Results, Data Presentation Schedule - Research Reports on AstraZeneca, Illumina, Novartis, Lilly and Alexion 8:30 a.m. Aug. 26, 2014 - PR Newswire - PRF
Alexion Initiates Multinational Registration Trial of Eculizumab for the Prevention of Delayed Graft Function (DGF) after Kidney Transplantation 6:30 a.m. Aug. 25, 2014 - BusinessWire - BZX
Technical Updates, Study Outcomes, Project Approvals, and Quarterly Performance Reviews - Research Reports on Alexion, Novartis, CB&I, L-3 and Emerson 8:40 a.m. Aug. 15, 2014 - PR Newswire - PRF
Researchers to Present New Data on Asfotase Alfa in Pediatric Patients with Hypophosphatasia at the American Society for Bone and Mineral Research 2014 Annual Meeting 4:57 p.m. Aug. 13, 2014 - BusinessWire - BZX
Cannabis Should Be Treated as an Agricultural Commodity, Not a Biotech Investment 2:44 p.m. Aug. 11, 2014 - ACCESSWIRE
Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma 8:40 a.m. Aug. 11, 2014 - PR Newswire - PRF
Financial Results, FDA Approvals, Orphan Drug Designations, and Certificates - Research Reports on Idenix, Baxter, Alexion, Alere and Zoetis 9:10 a.m. Aug. 7, 2014 - PR Newswire - PRF
European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG) 6:30 a.m. Aug. 1, 2014 - BusinessWire - BZX
Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis 8:40 a.m. July 29, 2014 - PR Newswire - PRF
European Medicines Agency Accepts Marketing Authorization Application for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia 6:15 a.m. July 24, 2014 - BusinessWire - BZX
Leadership Appointments, Earnings Conference Calls, Milestone Payments, and Technical Updates - Analyst Notes on Illumina, Alexion, Incyte, Clovis and Keryx 8:10 a.m. July 17, 2014 - PR Newswire - PRF
Alexion Announces the Appointments of David R. Brennan, M. Michele Burns and Christopher J. Coughlin to Its Board of Directors 8:02 a.m. July 16, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals to Report Second Quarter 2014 Results on Thursday, July 24, 2014 10:00 a.m. July 10, 2014 - BusinessWire - BZX
Market Activity and Upcoming Quarterly Results - Analyst Notes on Bristol-Myers Squibb, Abbott, Alexion, Mallinckrodt and Baxter 6:10 a.m. July 8, 2014 - PR Newswire - PRF
(0)
(0)